J&J to Pay $2.2B to Settle Marketing Allegations

J&J to pay .2B to settle marketing allegations
Marketing materials distributed by these sales representatives emphasized Risperdal as a treatment for seniors suffering from anxiety, agitation, depression and hostility, but did not mention that the drug was only FDA-approved for schizophrenia. At … Read more on San Francisco Chronicle

Johnson & Johnson pay .2 billion to settle prescription drug dispute
WASHINGTON — Johnson & Johnson has agreed to pay more than $ 2.2 billion to resolve criminal and civil allegations that the company promoted powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients, the Department of … Read more on Tri-Valley Herald

Former Castro Valley home resident under psychiatric care
Bascom appeared unable to take care of himself, so he was taken to Santa Clara Valley Medical Center in San Jose, Stenderup said. There, he was … He has also been arrested for public drunkenness, minor drug offenses and petty theft, authorities say … Read more on San Francisco Chronicle